Advanced MR Imaging of Gliomas: An Update

Recent advances in the treatment of cerebral gliomas have increased the demands on noninvasive neuroimaging for the diagnosis, therapeutic planning, tumor monitoring, and patient outcome prediction. In the meantime, improved magnetic resonance (MR) imaging techniques have shown much potentials in evaluating the key pathological features of the gliomas, including cellularity, invasiveness, mitotic activity, angiogenesis, and necrosis, hence, further shedding light on glioma grading before treatment. In this paper, an update of advanced MR imaging techniques is reviewed, and their potential roles as biomarkers of tumor grading are discussed.

• Publication year

  2013

• Venue

  BioMed Research International

• Publication date

  2013-06-04

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1155/2013/970586PMID 23862163PMCID 3686060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis

  2013cited by this paper
• IDH1 mutations in grade II astrocytomas are associated with unfavorable progression‐free survival and prolonged postrecurrence survival

  2012cited by this paper
• "Tumoral pseudoblush" identified within gliomas at high-spatial-resolution ultrahigh-field-strength gradient-echo MR imaging corresponds to microvascularity at stereotactic biopsy.

  2012cited by this paper
• Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma

  2012influential reference
• Gliomas: diffusion kurtosis MR imaging in grading.

  2012cited by this paper
• I and J

  2012cited by this paper
• Longitudinal brain imaging of five malignant glioma patients treated with bevacizumab using susceptibility-weighted magnetic resonance imaging at 7 T.

  2012cited by this paper
• Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging.

  2012cited by this paper
• Differentiation of Pyogenic Brain Abscesses from Necrotic Glioblastomas with Use of Susceptibility-Weighted Imaging

  2012cited by this paper
• Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.

  2011cited by this paper
• Isolated Diffusion Restriction Precedes the Development of Enhancing Tumor in a Subset of Patients with Glioblastoma

  2011cited by this paper
• Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

  2010cited by this paper
• Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.

  2010cited by this paper
• Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma

  2010cited by this paper
• MR−Based Molecular Imaging of the Brain: The Next Frontier

  2010cited by this paper
• Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

  2010cited by this paper
• Distinction between pyogenic brain abscess and necrotic brain tumour using 3-tesla MR spectroscopy, diffusion and perfusion imaging

  2010cited by this paper
• Combination of high-resolution susceptibility-weighted imaging and the apparent diffusion coefficient: added value to brain tumour imaging and clinical feasibility of non-contrast MRI at 3 T.

  2010cited by this paper
• Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas

  2010cited by this paper
• Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.

  2009cited by this paper
• Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

  2009cited by this paper
• MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

  2009cited by this paper
• Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

  2009cited by this paper
• Distinction between pyogenic brain abscess and necrotic brain tumour using 3-tesla MR spectroscopy, diffusion and perfusion imaging.

  2009cited by this paper
• Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

  2008cited by this paper
• Time course of imaging changes of GBM during extended bevacizumab treatment

  2008cited by this paper
• Bevacizumab for recurrent malignant gliomas

  2008cited by this paper
• Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas

  2008cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.

  2008cited by this paper
• Advanced MRI in the management of adult gliomas

  2007cited by this paper
• Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma.

  2007cited by this paper
• Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas.

  2007cited by this paper
• Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features

  2007cited by this paper
• The role of advanced MR imaging in understanding brain tumour pathology

  2007cited by this paper
• Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging

  2007cited by this paper
• Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?

  2006cited by this paper
• Identification of expressed genes characterizing long-term survival in malignant glioma patients

  2006cited by this paper
• Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not.

  2006cited by this paper
• Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging

  2006cited by this paper
• Mechanisms of angiogenesis in gliomas

  2006cited by this paper
• Low-grade and anaplastic gliomas: differences in architecture evaluated with diffusion-tensor MR imaging.

  2006cited by this paper
• Physiologic and metabolic magnetic resonance imaging in gliomas.

  2006cited by this paper
• Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis.

  2006influential reference
• Correlation Among Pathology, Genotype, and Patient Outcomes in Glioblastoma

  2006cited by this paper
• Molecular pathology of malignant gliomas.

  2006cited by this paper
• Glioblastoma multiforme with atypical diffusion-weighted MR findings.

  2005cited by this paper
• Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas.

  2005cited by this paper
• Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.

  2005cited by this paper
• Principles of cerebral perfusion imaging by bolus tracking

  2005cited by this paper
• Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo.

  2005cited by this paper
• Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imaging

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Magnetic susceptibility-weighted MR phase imaging of the human brain.

  2005cited by this paper
• Molecular pathology and clinical characteristics of oligodendroglial neoplasms

  2005cited by this paper
• Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.

  2005cited by this paper
• Vascular microenvironment in gliomas.

  2004cited by this paper
• Susceptibility weighted imaging (SWI)

  2004cited by this paper
• Genetic Pathways to Glioblastoma

  2004cited by this paper
• Atypical diffusion-weighted magnetic resonance findings in glioblastoma multiforme.

  2004cited by this paper
• Pathology and molecular genetics of astrocytic gliomas

  2004cited by this paper
• Gene Expression Profiling of Gliomas Strongly Predicts Survival

  2004cited by this paper
• Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

  2004cited by this paper
• Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.

  2004cited by this paper
• Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature.

  2004cited by this paper
• Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data.

  2003cited by this paper
• Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion?

  2003cited by this paper
• Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic Subtypes

  2003cited by this paper
• Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors.

  2003cited by this paper
• Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI

  2002cited by this paper
• Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo

  2002cited by this paper
• Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.

  2002cited by this paper
• Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings.

  2001cited by this paper
• Identification of the corticospinal tracts achieved using blood-oxygen-level-dependent and diffusion functional MR imaging in patients with brain tumors.

  2001cited by this paper
• High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas.

  2000influential reference
• Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.

  2000cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.

  2000cited by this paper
• Loss of Heterozygosity on Chromosome 19 in Secondary Glioblastomas

  2000cited by this paper
• Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast‐enhanced dynamic MR imaging

  2000cited by this paper
• Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

  2000cited by this paper
• Correlation of myo-inositol levels and grading of cerebral astrocytomas.

  2000cited by this paper
• VEGF in Brain Tumors

  2000cited by this paper
• Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.

  2000cited by this paper
• Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.

  2000cited by this paper
• Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas

  2000cited by this paper
• Primary and secondary glioblastomas: from concept to clinical diagnosis.

  1999cited by this paper
• Role of diffusion-weighted echo-planar MRI in distinguishing between brain abscess and tumour: a preliminary report

  1999cited by this paper
• Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas

  1999cited by this paper
• Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy.

  1999cited by this paper
• MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation.

  1999cited by this paper
• In vivo single voxel 1H MRS of glial brain tumors: correlation with tissue histology and in vitro MRS.

  1998cited by this paper
• Functional image-guided surgery of intracranial tumors located in or near the sensorimotor cortex.

  1998cited by this paper
• Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets.

  1997cited by this paper
• A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.

  1997cited by this paper
• The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors.

  1997cited by this paper
• Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.

  1997cited by this paper
• Measurement of cerebral blood volume via the relaxing effect of low-dose gadopentetate dimeglumine during bolus transit.

  1996cited by this paper
• Prognostic significance of Ki‐67 labeling indices obtained using MIB‐1 monoclonal antibody in patients with supratentorial astrocytomas

  1996cited by this paper
• Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.

  1995cited by this paper

• Clinical and VASARI Features to Predict CDKN2A/B Homozygous Deletion in IDH-Mutant Astrocytomas: A Multicenter Study

  2025cites this paper
• CSF1R and macrophage infiltration: Integrated magnetic resonance imaging radiomics and deep learning-driven models for the preoperative assessment of glioma.

  2025cites this paper
• Multi-Sequence MRI radiomics model for discrimination of recurrence and pseudoprogression in gliomas.

  2025cites this paper
• Multi‐Omics Integration for Advancing Glioma Precision Medicine

  2025cites this paper
• Multimodal Integration of MRI and Genetic Information for Glioblastoma Survival Prediction

  2025cites this paper
• Cleavage of the vascular matrix attracts glioblastoma cells to infiltrate the brain parenchyma

  2024cites this paper
• A Novel 3D InceptionNet Model: Architecture and Applications in Hyperspectral Brain Image Classification

  2024cites this paper
• A Multi-Objective Evolutionary Stacking Integration Approach for Survival Prediction in GBM Patients

  2024cites this paper
• Ultra-high b-value DWI accurately identifies isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas

  2024cites this paper
• Deep Convolutional Neural Network for Brain Tumor Segmentation

  2023cites this paper
• Intelligent framework for brain tumor grading using advanced feature analysis

  2023cites this paper
• Spatial distribution and functional relevance of FGFR1 and FGFR2 expression for glioblastoma tumor invasion

  2023cites this paper
• Brain multi-parametric MRI tumor subregion segmentation via hierarchical substructural activation network

  2022cites this paper
• Pre-contrast MAGiC in treated gliomas: a pilot study of quantitative MRI

  2022cites this paper
• Role of Magnetic Resonance Imaging (MRI) in grading gliomas comparable with pathology: A cross-sectional study from Syria

  2022cites this paper
• Differentiation of malignant brain tumor types using intratumoral and peritumoral radiomic features

  2022cites this paper
• Imaging Findings and Clinical Analysis of Primary Intracranial Pure Yolk Sac Tumors in Children and Adolescents: A Retrospective Study from China

  2022cites this paper
• The role of diffusion-weighted MRI in characterization of intracranial cystic lesions

  2022cites this paper
• Cascaded mutual enhancing networks for brain tumor subregion segmentation in multiparametric MRI

  2022cites this paper
• Fully Automated Segmentation of Brain Tumor from Multiparametric MRI Using 3D Context Deep Supervised U-Net.

  2021cites this paper
• Cystic-appearing Intracranial neoplastic lesions

  2021cites this paper
• Monoexponential, biexponential and stretched exponential models of diffusion weighted magnetic resonance imaging in glioma in relation to histopathologic grade and Ki-67 labeling index using high B values.

  2021cites this paper
• Evaluating potential of multi-parametric MRI using co-registered histology: Application to a mouse model of glioblastoma.

  2021cites this paper
• Can High b Value Diffusion Be a Surrogate Marker for PET—A MR/PET Study in Neurooncology Set Up

  2021cites this paper
• Radiomics-Based Machine Learning Classification for Glioma Grading Using Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging

  2021cites this paper
• Preliminary evaluation of cerebral 18F-DOPA PET/CT in the differential diagnosis of brain lesions in inconclusive MR.

  2021cites this paper
• Analysis of diffusion tensor imaging metrics for glioma grading at 3T: Comparison with histopathology as gold standard

  2021cites this paper
• Accelerated 3D whole-brain T1, T2, and proton density mapping: feasibility for clinical glioma MR imaging

  2021cites this paper
• Fully automated segmentation of brain tumor from multiparametric MRI using 3D context U-Net with deep supervision

  2021cites this paper
• Radiohistogenomics of pediatric low-grade neuroepithelial tumors

  2021cites this paper
• Unilateral posterior reversible encephalopathy syndrome characterized with a long and gradually exacerbating course over 3 years and that presented propofol infusion syndrome – A case report

  2021cites this paper
• Cerebral microcirculation in glioblastoma: A major determinant of diagnosis, resection, and drug delivery

  2021cites this paper
• Penta-fluorophenol: a Smiles rearrangement-inspired cysteine-selective fluorescent probe for imaging of human glioblastoma

  2020cites this paper
• Pseudoprogression

  2020cites this paper
• The role of multi-parametric magnetic resonance imaging (MRI) in early prediction of malignant transformation of low-grade Gliomas (A Systematic review)

  2020influential citation
• Differentiating non enhancing grade II gliomas from grade III gliomas using diffusion tensor imaging and dynamic susceptibility contrast MRI.

  2020cites this paper
• 3D printing of diffuse low-grade gliomas involving eloquent cortical areas and subcortical functional pathways: a technical note.

  2020cites this paper
• Propofol Inhibits Cell Proliferation, Migration, and Invasion via mir-410-3p/Transforming Growth Factor-β Receptor Type 2 (TGFBR2) Axis in Glioma

  2020cites this paper
• Valoración preliminar de la 18F-DOPA PET/TC cerebral en el diagnóstico diferencial de lesiones cerebrales con RM no concluyente

  2020cites this paper
• Lesiones oncológicas intracraneales de apariencia quística

  2020cites this paper
• Susceptibility-Weighted Imaging in Grading of Infiltrative Glial Tumors

  2020cites this paper
• A study to nd the characteristic imaging ndings of various ring- enhancing lesions using MR imaging

  2020cites this paper
• Noninvasively Evaluating the Grading of Glioma by Multiparametric Magnetic Resonance Imaging.

  2020cites this paper
• Study of Correlation between Magnetic Resonance Spectroscopy Metabolites and Glioma Grading

  2019cites this paper
• High-Grade Gliomas in Children with Neurofibromatosis Type 1: Literature Review and Illustrative Cases

  2019cites this paper
• Mass Effect Deformation Heterogeneity (MEDH) on Gadolinium-contrast T1-weighted MRI is associated with decreased survival in patients with right cerebral hemisphere Glioblastoma: A feasibility study

  2019cites this paper
• A Critical Appraisal of the Quality of Glioma Imaging Guidelines Using the AGREE II Tool: A EuroAIM Initiative

  2019cites this paper
• Preoperative Imaging (MRI, Functional MRI, CT)

  2019cites this paper
• A Mistaken Diagnosis of Secondary Glioblastoma as Parasitosis

  2019cites this paper
• Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma

  2018cites this paper
• Title Voxel-based clustered imaging by multiparameter diffusiontensor images for glioma grading

  2018influential citation
• Stretched-exponential model diffusion-weighted imaging as a potential imaging marker in preoperative grading and assessment of proliferative activity of gliomas.

  2018cites this paper
• What's Old Is New Again: The Sacroiliac Joint as a Cause of Lateralizing Low Back Pain

  2018cites this paper
• Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging

  2018cites this paper
• Utilizing 18F‐fluoroethyl‐l‐tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI

  2018cites this paper
• Glioneuronal Tumor with Neuropil-Like Islands in the Cerebellum: A Case Report

  2018cites this paper
• Advanced and amplified BOLD fluctuations in high‐grade gliomas

  2018cites this paper
• Characterization of an Orthotopic Rat Model of Glioblastoma Using Multiparametric Magnetic Resonance Imaging and Bioluminescence Imaging

  2018cites this paper
• The Methods Used in Nonparametric Covariance Analysis Parametrik Olmayan Kovaryans Analizinde Kullanılan Metotlar

  2018cites this paper
• Comparison of Pathological Indexes ( Ki-67 , p 53 ) , and Perfusion / Diffusion MR Parameters in Glioma Staging Gliom Evrelemesinde Patolojik İndekslerin ( Ki-67 , p 53 ) ve Perfüzyon / Difüzyon MR

  2018cites this paper
• Dynamic T1-Contrast-Enhanced 3T-MRI of peritumoral white matter in differentiation between glioblastomas and metastases

  2017cites this paper
• Multi-parametric imaging of tumors using 3T magnetic resonance

  2017cites this paper
• Radiomic Phenotyping in Brain Cancer to Unravel Hidden Information in Medical Images

  2017cites this paper
• Three-Dimensional Printed Modeling of Diffuse Low-Grade Gliomas and Associated White Matter Tract Anatomy

  2017cites this paper
• Proton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma

  2017cites this paper
• Canine brain tumours: a model for the human disease?

  2017cites this paper
• Alexander Disease

  2017cites this paper
• Apparent diffusion coefficient measurement in glioma: Influence of region‐of‐interest determination methods on apparent diffusion coefficient values, interobserver variability, time efficiency, and diagnostic ability

  2017cites this paper
• Angiotensin II type 2 receptor signalling promotes glioblastoma growth : a novel target for therapeutic intervention

  2017cites this paper
• PET/MRI: Multiparametric imaging of brain tumors.

  2017cites this paper
• Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience

  2017cites this paper
• Proton MR spectroscopic imaging of human glioblastomas at 1.5 Tesla.

  2017cites this paper
• Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.

  2017cites this paper
• MULTIPARAMeTRIcKé zobRAzeNí NáDoRů NA 3 T MAgNeTIcKé RezoNANcI

  2017influential citation
• Grading of Glioma Tumors by Analysis of Minimum Apparent Diffusion Coefficient and Maximum Relative Cerebral Blood Volume

  2016cites this paper
• Potential Utility of Visually AcceSAble Rembrandt Images Assessment in Brain Astrocytoma Grading

  2016cites this paper
• Thérapies par rayonnements appliquées au cas du glioblastome : Intérêt du suivi par spectroscopie et imagerie de diffusion par résonance magnétique.Vers une thérapie bimodale.

  2016cites this paper
• Diencephalic and Other Deep Brain Tumors

  2016cites this paper
• Clinical, Pathological, and Molecular Prognostic Parameters in Glioblastoma Patients Undergoing Chemo- and Radiotherapy

  2016cites this paper
• Imaging Targeted Therapy Response and Resistance in Glioblastoma

  2016cites this paper
• Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.

  2016cites this paper
• Radiomics in Brain Tumors: An Emerging Technique for Characterization of Tumor Environment.

  2016cites this paper
• Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: Single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imaging

  2016cites this paper
• Advanced neuroimaging in the clinic: critical appraisal of the evidence base.

  2016cites this paper
• Integration of magnetic resonance spectroscopic imaging into the radiotherapy treatment planning. (Intégration des cartes métaboliques d'imagerie spectroscopique à la planification de radiothérapie)

  2016cites this paper
• The Diagnostic Ability of Follow-Up Imaging Biomarkers after Treatment of Glioblastoma in the Temozolomide Era: Implications from Proton MR Spectroscopy and Apparent Diffusion Coefficient Mapping

  2015cites this paper
• Effect of TNFRSF6B neutralization antibody on cell growth suppression and apoptosis induction in glioma cells.

  2015cites this paper
• Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor.

  2015cites this paper
• OKN‐007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model

  2015cites this paper
• La Pet amb 11c-metionina com a factor pronòstic i en la caracterització dels gliomes

  2015influential citation
• Patient management problem-preferred responses.

  2015cites this paper
• Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts

  2015cites this paper
• Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: efficacy in preoperative grading

  2014cites this paper
• Imaging of brain tumors.

  2014cites this paper
• Glioma grading using apparent diffusion coefficient map: application of histogram analysis based on automatic segmentation

  2014cites this paper
• Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading

  2014influential citation
• AWARD NUMBER: W81XWH-12-1-0282 TITLE: Monoamine Oxidase A: A Novel Target for Progression and Metastasis of Prostate Cancer

  2013cites this paper
• From Imaging to Prognosis: Crafting Clinical Nomograms Based on a Multi-Sequence MRI Radiomics Model for Non-Invasive Glioma Survival Prediction

  year unknowncites this paper